Novartis AG is 26.1x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($283.13 B vs $10.86 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BMRN | NVS |
|---|---|---|
| Market cap | $10.86 B | $283.13 B |
| US-listed rank | #899 | #47 |
| Revenue (latest FY) | $3.22B | - |
| Net income (latest FY) | $348.90M | - |
| Net margin | 10.8% | - |
| P/E (trailing FY) | 31.1 | - |
| SEC filings | 2,709 | 947 |
Novartis AG is 26.1x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($283.13 B vs $10.86 B).
Full pages: BIOMARIN PHARMACEUTICAL INC and Novartis AG, or browse the full rankings.